Leading academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide rely on MediBeacon technology. More >>
Measurement of GFR is widely accepted as the best indicator of kidney function. A clinically practical and accurate real-time point of care methodology holds promise. More >>
Fluorescent agent angiography has the potential to aid in diagnosis and monitoring of vasculature leakage seen in Diabetic Retinopathy, Macular Degeneration and Retinal Vasculitis. More >>
Intraoperative identification of ureter or ureteral injury is critical to prevent serious complications. Use of fluorescent agents could potentially aid in surgical visualization. More >>
Industry leaders including scientists and clinicians are behind fluorescence enabled technology that has the potential to impact global health. More >>
Let us know how we can continue the conversation. More >>
EXCLUSIVE USER CONTENT:
Additional resources and information for researchers.
MediBeacon is committed to providing continuing technical support to our growing community of preclinical research clients. Content is updated regularly so our community can stay abreast of the latest developments and leading edge techniques.
Follow the progress: Sign up today to receive notifications of milestones, news and updates on MediBeacon fluorescent technology.